Peptide/GLP-1 Complications: 11 Hidden Risks and Side Effects You Must Know CoverWell Aug 19, 2025 4 min read Introduction to Peptide and GLP-1 Therapies Peptide and GLP-1 therapies have rapidly emerged as game-changers in modern healthcare
GLP-1 microdosing is suitable for: Individuals at risk for chronic diseases (cardiovascular, neurological, renal) Those pursuing longevity or preventive health measures Patients seeking sustainable wellness beyond weight loss Consultation with your doctor is required to confirm eligibility
"Further, the potential short- and long-term risks to the breastfeeding infant have been insufficiently studied," the authors noted
The overall market size is expected to grow by 8X during the same period, supported by expanding treatment eligibility, increasing public reimbursement coverage, and growing clinical evidence for cardiovascular risk reduction benefits
However, several critical challenges persist, including the substantial burden imposed by frequent intravitreal injections and a therapeutic focus that predominantly addresses vascular pathology while offering limited interventions for the underlying neurodegenerative processes
Browse Catalogue Research Updates From Virtus Peptides New compounds, restocks, and fresh COAs